Message from the CEO

Well positioned for global rollout

As prosperity and life expectancy are increasing across the world, the burden of chronic illness such as cancer and cardiovascular diseases is also rapidly increasing. Obesity and diabetes show worrying trends, not only because they already affect a large proportion of the population, but also because they have started to appear earlier in life. At the same time, awareness of and interest in health and performance are also growing, as is the desire to invest in our own and our children's health and development. This includes medical solutions for alleviating and preventing chronical diseases as well as new ways of thinking about food and nutrition.

Smartfish nutrition solutions address this growing market. The purpose we pursue is an important one: “Enabling you to be the best you can possibly be, whether you are a patient fighting a life-threatening disease or a professional athlete pursuing your dreams”.

Our strong product portfolio targets both the fast-growing field of medical nutrition and the consumer health market. We facilitate healthy growing and ageing, support metabolic health – and help athletes improve their results and recovery after training and competition with our sports nutrition.

A strong foundation for future growth
Our patented emulsion technology platform and Omega-3-enhanced nutritional drinks and emulsions are at the core of our business. We have a unique combination of great tasting products supported by intellectual property and patents. Their efficacy is backed by clinical studies. Our nutrition products have a demonstrated ability to distribute and integrate key health-promoting ingredients into the human body.

From its inception in 2001, Smartfish technology has attracted interest from the research community. Studies validating our technology have been performed with the involvement of more than 50 universities and hospital institutions. Taken together with our own clinical studies and patents, this builds a strong proprietary scientific foundation which we will continue to develop.

While we have been developing our technology and products, we have also established strategic partnerships with leading players in selected international markets. We find the Asian market of particular interest with its vast size and growing interest in new health and nutrition solutions.

Expanding international cooperation
Smartfish has built a solid platform for a successful future that I anticipate with great confidence. In 2018 and early 2019, years of development work have started to bear fruit. We are experiencing keen interest from recognised international partners in the fields of medical nutrition and consumer health.

We are also very proud to have successfully expanded the partnership with our distributor in Hong Kong to include all Smartfish consumer health products in the Greater China region and beyond.


Validation of our cachexia products
Our strategy includes even further scientific validation of our products. Positive results from the first Smartfish clinical trial for COPD were published in 2017 in the Journal of Cachexia, Sarcopenia and Muscle (JCSM). We are proud to announce that the report on the clinical trial was one of the journal’s most downloaded articles in 2018. Publication of the results from our cancer study is planned for 2019. In the future, we anticipate that malnutrition in patients with other diseases such as, e.g. Chronic Kidney Disease and Congestive Heart Failure be managed based on our emulsion technology. This will enable Smartfish to target new market segments.

Roll-out of our medical nutrition and consumer health portfolios in 2019
With two strong commercial agreements in place, we expect 2019 to mark the international rollout of our medical nutrition and consumer health portfolios. We build our organisational structure to deliver on our ambitious growth objectives by strengthening our scientific, commercial and operational teams. By early 2020, I look forward to presenting the progress and results of the first year of roll-out.

Dedication to succeed
I would like to thank everyone who has contributed to the development of Smartfish. This includes our highly skilled, experienced and dedicated staff, our scientific partners, and our loyal and tireless partners in manufacturing, marketing and distribution. I would also like to thank our shareholders for their patience and support throughout the years. Their commitment and backing are crucial to our success.

Finally, I would like to stress the value of our Board of Directors and Advisory Board. They both consist of highly competent people, with a drive to guide Smartfish in the right direction, helping to open doors and build relationships that would not be possible otherwise. On top of this, we have ongoing cooperation with more than 50 universities and hospital institutions, which is fundamental for our continued R&D.

The entire Smartfish team is definitely “punching above our weight”. I believe we have a bright future ahead of us.

Read More

Core technology

Market

Organisation & Operations